Carolyn Bramante

Study from Former KL2 Scholar Shows Metformin Lowers the Risk of Getting Long COVID

In a new study published in The Lancet Infectious Diseases, a team of University of Minnesota researchers found that metformin, a drug commonly used to treat diabetes, prevents the development of long COVID. Former KL2 scholar Carolyn Bramante, MD, is the principal investigator.

Other News

A scientist holding a model of a virus
This month marks the 20th anniversary of the Institute for Molecular Virology.
Hand people holding Magnifier focus to plus symbol and healthcare medical icon
According to the Centers for Medicare & Medicaid Services (CMS), 66.2 million Americans were enrolled in Medicare as of July 2023.
Medical professionals standing in front of a barn
We are working to ensure the discoveries and innovations in health care are available for all Minnesotans.